222 related articles for article (PubMed ID: 12063828)
1. Early detection of pancreatic carcinoma.
Rosty C; Goggins M
Hematol Oncol Clin North Am; 2002 Feb; 16(1):37-52. PubMed ID: 12063828
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of pancreatic cancer.
Hilgers W; Rosty C; Hahn SA
Hematol Oncol Clin North Am; 2002 Feb; 16(1):17-35, v. PubMed ID: 12063826
[TBL] [Abstract][Full Text] [Related]
3. The molecular genetics of pancreatic ductal carcinoma.
Sohn TA
Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of exocrine pancreatic cancer.
Soto JL; Barbera VM; Saceda M; Carrato A
Clin Transl Oncol; 2006 May; 8(5):306-12. PubMed ID: 16760004
[TBL] [Abstract][Full Text] [Related]
5. Hereditary factors in pancreatic cancer.
Lynch HT; Brand RE; Lynch JF; Fusaro RM; Kern SE
J Hepatobiliary Pancreat Surg; 2002; 9(1):12-31. PubMed ID: 12021894
[TBL] [Abstract][Full Text] [Related]
6. Early detection markers in Pancreas Cancer.
Farrell JJ; van Rijnsoever M; Elsaleh H
Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037
[TBL] [Abstract][Full Text] [Related]
7. Detection and proteomic characterization of extracellular vesicles in human pancreatic juice.
Osteikoetxea X; Benke M; Rodriguez M; Pálóczi K; Sódar BW; Szvicsek Z; Szabó-Taylor K; Vukman KV; Kittel Á; Wiener Z; Vékey K; Harsányi L; Szűcs Á; Turiák L; Buzás EI
Biochem Biophys Res Commun; 2018 Apr; 499(1):37-43. PubMed ID: 29550476
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic alterations in ductal pancreatic adenocarcinomas.
Kern SE
Med Clin North Am; 2000 May; 84(3):691-5, xi. PubMed ID: 10872425
[TBL] [Abstract][Full Text] [Related]
9. Molecular markers of pancreatic cancer: development and clinical relevance.
Fry LC; Mönkemüller K; Malfertheiner P
Langenbecks Arch Surg; 2008 Nov; 393(6):883-90. PubMed ID: 18266003
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
[TBL] [Abstract][Full Text] [Related]
11. Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma.
Chang JC; Kundranda M
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335509
[TBL] [Abstract][Full Text] [Related]
12. [Hereditary gastric and pancreatic cancer predisposition syndromes].
Leoz ML; Sánchez A; Carballal S; Ruano L; Ocaña T; Pellisé M; Castells A; Balaguer F; Moreira L
Gastroenterol Hepatol; 2016; 39(7):481-93. PubMed ID: 26916701
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of CA-19-9 in pancreatic carcinoma.
Nakao A; Oshima K; Nomoto S; Takeda S; Kaneko T; Ichihara T; Kurokawa T; Nonami T; Takagi H
Semin Surg Oncol; 1998; 15(1):15-22. PubMed ID: 9671952
[TBL] [Abstract][Full Text] [Related]
14. Genetics and prevention of pancreatic cancer.
Vimalachandran D; Ghaneh P; Costello E; Neoptolemos JP
Cancer Control; 2004; 11(1):6-14. PubMed ID: 14749618
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathobiology of pancreatic adenocarcinoma.
Mangray S; King TC
Front Biosci; 1998 Nov; 3():D1148-60. PubMed ID: 9820739
[TBL] [Abstract][Full Text] [Related]
16. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.
Vasen HF; Wasser M; van Mil A; Tollenaar RA; Konstantinovski M; Gruis NA; Bergman W; Hes FJ; Hommes DW; Offerhaus GJ; Morreau H; Bonsing BA; de Vos tot Nederveen Cappel WH
Gastroenterology; 2011 Mar; 140(3):850-6. PubMed ID: 21129377
[TBL] [Abstract][Full Text] [Related]
18. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
19. Advances in pancreatic cancer detection.
Tanase CP; Neagu M; Albulescu R; Hinescu ME
Adv Clin Chem; 2010; 51():145-80. PubMed ID: 20857621
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9.
Ballehaninna UK; Chamberlain RS
Tumour Biol; 2013 Dec; 34(6):3279-92. PubMed ID: 23949878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
